scholarly journals Successful Treatment for Hepatic Encephalopathy Aggravated by Portal Vein Thrombosis with Balloon-Occluded Retrograde Transvenous Obliteration

2011 ◽  
Vol 5 (2) ◽  
pp. 366-371 ◽  
Author(s):  
Naotaka Hashimoto ◽  
Tomohiko Akahoshi ◽  
Tetsuya Shoji ◽  
Morimasa Tomikawa ◽  
Norifumi Tsutsumi ◽  
...  
Keyword(s):  
Hepatic Encephalopathy ◽  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Successful Treatment ◽  
Vein Thrombosis

scholarly journals Successful treatment of a huge hepatic carcinoma with right portal vein thrombosis

Medicine ◽  
2020 ◽  
Vol 99 (17) ◽  
pp. e19636
Author(s):  
Kezhong Tang ◽  
Bo Zhang ◽  
Linping Dong ◽  
Lantian Wang ◽  
Yecheng Jin ◽  
...  
Keyword(s):  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Successful Treatment ◽  
Hepatic Carcinoma ◽  
Vein Thrombosis

Relationship between underlying causes of HCC and its complications.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e13123-e13123
Author(s):  
Daniel Kyung ◽  
Stuthi Perimbeti ◽  
Bolanle Adepoju ◽  
Shaun Bryan Hanson ◽  
Michael Joseph McCormack ◽  
...  
Keyword(s):  
Hepatic Encephalopathy ◽  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Bivariate Analysis ◽  
Chi Square ◽  
Esophageal Variceal ◽  
Esophageal Variceal Bleeding ◽  
Vein Thrombosis ◽  
The Us ◽  
Chi Square Test

e13123 Background: Hepatocellular carcinoma (HCC) remains the 4th leading cause of cancer mortality in the US. While mortality varies by stage, the presence of certain HCC-related complications contribute to increased mortality. In this study, we assessed whether the underlying cause for HCC influenced the frequency of common complications. Methods: The National Inpatient Sample between 1999 and 2014 was analyzed using ICD-9 codes. The ICD-9 code for HCC was used to extract all admissions from the years 1999-2014 and weighted to approximate the full inpatient population of the US over the 16 year interval. The prevalence of HCC-related complications were calculated for portal vein thrombosis (PVT), erythrocytosis, peritonitis, esophageal variceal bleeding (EVB), portal hypertension (Portal HTN) and hepatic encephalopathy (HE). Bivariate analysis using Chi square test was performed to compare the percentages of each complication with underlying risk factors for HCC (HBV, HCV, NASH and alcohol). Results: Total of 131,115 admissions (weighted = 648,732) was identified to have HCC. Conclusions: Portal HTN was the most common complication associated with HCV and NASH, whereas hepatic encephalopathy was most frequently seen with alcohol and PVT with HBV, respectively. Alcohol was associated with the highest rate of HCC-complications with the exception of portal vein thrombosis. HBV was associated with the lowest frequencies of complications except for PVT, for which it was the highest. Future studies might look at whether disease modifying measures such as cessation of alcohol and eradication of active HBV, HCV would impact the natural history of HCC.[Table: see text][Table: see text]

scholarly journals Cognitive Impairement in Non-Cirrhotic Portal Hypertension: Highlights on Physiopathology, Diagnosis and Management

2021 ◽  
Vol 11 (1) ◽  
pp. 101
Author(s):  
Stefania Gioia ◽  
Silvia Nardelli ◽  
Oliviero Riggio ◽  
Jessica Faccioli ◽  
Lorenzo Ridola
Keyword(s):  
Portal Hypertension ◽  
Hepatic Encephalopathy ◽  
Portal Vein ◽  
Vascular Disease ◽  
Portal Vein Thrombosis ◽  
Case Reports ◽  
Diagnostic Tools ◽  
Western World ◽  
Type B ◽  
Vein Thrombosis

Hepatic encephalopathy (HE) is one of the most frequent complications of cirrhosis. Several studies and case reports have shown that cognitive impairment may also be a tangible complication of portal hypertension secondary to chronic portal vein thrombosis and to porto-sinusoidal vascular disease (PSVD). In these conditions, representing the main causes of non-cirrhotic portal hypertension (NCPH) in the Western world, both overt and minimal/covert HE occurs in a non-neglectable proportion of patients, even lower than in cirrhosis, and it is mainly sustained by the presence of large porto-systemic shunt. In these patients, the liver function is usually preserved or only mildly altered, and the development of porto-systemic shunt is either spontaneous or iatrogenically frequent; HE is an example of type-B HE. To date, in the absence of strong evidence and large cooperative studies, for the diagnosis and the management of HE in NCPH, the same approach used for HE occurring in cirrhosis is applied. The aim of this paper is to provide an overview of type B hepatic encephalopathy, focusing on its pathophysiology, diagnostic tools and management in patients affected by porto-sinusoidal vascular disease and chronic portal vein thrombosis.

scholarly journals Spontaneous thrombosis of large splenorenal shunt during balloon-occluded retrograde transvenous obliteration in a patient with chronic persistent hepatic encephalopathy. Is this catheter assisted trans-venous occlusion?

2017 ◽  
Vol 8 (1) ◽  
Author(s):  
Lijesh Kumar ◽  
Cyriac Abby Philips ◽  
Prakash Zacharias ◽  
Sudarshan Patil ◽  
Philip Augustine
Keyword(s):  
Hepatic Encephalopathy ◽  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Hepatic Dysfunction ◽  
Venous Occlusion ◽  
Splenorenal Shunt ◽  
Chronic Hepatic Encephalopathy ◽  
Vein Thrombosis ◽  
Portosystemic Shunts ◽  
First Time

Large spontaneous portosystemic shunts in cirrhosis are implicated in recurrent and/or chronic persistent hepatic encephalopathy. In long standing cases, these shunts lead to portal vein thrombosis and hepatic dysfunction. Balloon-occluded retrograde transvenous obliteration (BRTO) is an endovascular technique that is usually employed for shunt closure in the patients manifesting the features of chronic hepatic encephalopathy. There are several reports documenting systemic and portal vein thrombosis as a part of the procedure. We report first time a patient in whom the difficult and partial BRTO procedure led to the extensive thrombosis of the large splenorenal shunt itself without sclerosant instillation.

Successful treatment of acute portal vein thrombosis with rivaroxaban

2013 ◽  
Vol 110 (10) ◽  
pp. 626-627 ◽  
Author(s):  
Sven Pannach ◽  
Jana Babatz ◽  
Jan Beyer-Westendorf
Keyword(s):  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Successful Treatment ◽  
Vein Thrombosis
Sign in / Sign up

Export Citation Format

Share Document